Public Company News

NYSE Content Advisory: Pre-Market update + S&P 500 ends August up nearly 2%

 NEW YORK, Sept. 2, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.? ? NYSE Content Advisory: Pre-Market update + S&P 500 ends August u...

2025-09-02 21:01 2396

Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program

 Milestone European deployment underscores growing global trust in?Lunit's AI for population-wide breast cancer screening SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that its solutions h...

2025-09-02 21:00 1464

High-Quality Urban Development Creates Policy Tailwinds, Luda Technology Group Limited (LUD.US) Well-Positioned to Benefit

 HONG KONG, Sept. 2, 2025 /PRNewswire/ -- The Guiding Opinions of the Central Committee of the Communist Party ofChina and the State Council on Promoting High-Quality Urban Development (the "Guiding Opinions") were recently officially released. Driven by this new policy impetus, capital markets ha...

2025-09-02 21:00 1346

Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer's disease and Dementia Data

 * Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related data * Enhancing dementia research by integrating AI imaging solutions with real-world data platforms SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ --? Neurophet...

2025-09-02 21:00 1644

Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants

 -??????? The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open untilNovember 20; final awardees to be announced inAugust 2026 -??????? Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndro...

2025-09-02 21:00 1534

Future FinTech Announces Agreement to Develop Advanced Rail Transport System

 NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Future FinTech Group Inc. (NASDAQ: FTFT; "Future FinTech", "FTFT", or the "Company"), a comprehensive financial and digital technology service provider, today announced that its wholly-owned subsidiary, Future Commercial Group Co. Ltd.,?has signed a Project...

2025-09-02 20:30 1439

MDJM Announces Opening of Bar at Robin Hill Hotel, Unlocking New Revenue Stream and Enhancing Cultural Hospitality Offering

 LETHAM, Scotland, Sept. 2, 2025 /PRNewswire/ --?MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that it had received the final licensing approval on August 19, 2025 and officially opened a new bar on August 19, 2025 a...

2025-09-02 20:30 1336

Hyosung Heavy Industries Strengthens Global Position in Power Solutions Under Chairman Cho Hyun-joon's Leadership

 - Chairman Cho Emphasizes Power Infrastructure as Foundation of the AI Economy, Identifies Power Equipment as Next Growth Driver - Hyosung Heavy Industries Signs Significant Power Equipment Supply Contracts Across North America andEurope - Hyosung's Advances in High-Voltage Direct Current (HVDC) T...

2025-09-02 20:30 1259

BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform

 XI'AN, China, Sept. 2, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds f...

2025-09-02 20:30 2498

TOYO Co., Ltd to Announce First Half 2025 Financial Results on September 8, 2025

TOKYO, Sept. 2, 2025 /PRNewswire/ --?TOYO Co., Ltd  (Nasdaq: TOYO) (OTC: TOYWF),?a solar solution company, today announced it will host a conference call to discuss first half 2025 results onMonday, September 8, 2025. Conference Call Details are as follow: Date:?Mon...

2025-09-02 20:30 1280

Firstsource named Horizon 3 Market Leader in HFS Horizons: The Best Service Providers for Mortgage Reinvention, 2025

MELBOURNE, Australia, Sept. 2, 2025 /PRNewswire/ --?Firstsource Solutions Limited ?(NSE: FSL) (BSE: 532809), a leading global provider of specialist domain-led Business Process Services (BPS) and an RP-Sanjiv Goenka Group company, has been recognized as a Horizon 3 M...

2025-09-02 20:19 1287

ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones

 ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS fromSept. 12 - 15 in Copenhagen, Denmark: * EFFICIENT, CONFIDENT DECISION MAKING: introducing AI-powered CIRRUS? PathFinder? clinical support tool now CE mark approved; presenting a fully integrate...

2025-09-02 20:00 923

SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

 * Approximately 800 children aged 12 months to 12 years in Korea and abroad, aiming for completion by 2027 * Rising demand for 2-dose regimen as international standards amid projected global market growth toUSD 6.3 billion by 3034 * SKBS continues strategic R&D to enhance global vaccine comp...

2025-09-02 19:00 1210

ChipMOS ANNOUNCES NT$480 MILLION SHARE REPURCHASE PROGRAM

HSINCHU, Sept. 2, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150  and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"),...

2025-09-02 18:00 2133

China Automotive Systems Announces Special Meeting of Stockholders on September 10, 2025

 A special meeting of stockholders will be held on Wednesday, September 10, 2025 , at9:00 AM local time or 9:00 PM EDT on Tuesday, September 9, 2025 WUHAN, China, Sept. 2, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS)?("CAAS" or the "Company"), a leading power steering componen...

2025-09-02 18:00 2130

Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting

 - Ascletis to present data from the U.S. Phase Ib clinical study of ASC30 oral tablet in oral discussion - On track to report topline data from Phase IIa clinical study of ASC30 oral tablet in participants with obesity or overweight in the fourth quarter of 2025 HONG KONG, Sept. 2, 2025 /PRNe...

2025-09-02 18:00 1040

Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights

 SHANGHAI, Sept. 2, 2025 /PRNewswire/ -- Peptides have recently emerged at the forefront of therapeutic innovation, with cyclic peptides gaining particular attention for their ability to?bridge the gap between small molecules and large biologics. Positioned between the two, cyclic peptides combine...

2025-09-02 17:52 980

IFA 2025: Premium brand AEG unveils most silent and efficient dishwasher ever made

 STOCKHOLM, Sept. 2, 2025 /PRNewswire/ -- Global appliance company Electrolux Group is showcasing breakthrough innovations across its focus areas at IFA 2025 inBerlin. Under its premium brand AEG, the company will reveal its new dishwasher range, New FAVORIT, at the AEG Media Conference onSeptembe...

2025-09-02 17:44 1029

UOB launches first regional Consumer Sentiment Index, revealing ASEAN consumers' confidence in the economy and personal finances

 The study also found that youths in ASEAN fall behind in financial readiness,? withSingapore's Gen Zs most at risk SINGAPORE, Sept. 2, 2025 /PRNewswire/ --?In the sixth edition of the?ASEAN Consumer Sentiment Study (ACSS)[1], the region's leading consumer confidence barometer, UOB launched ASEAN'...

2025-09-02 17:30 2268

Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy

 HONG KONG, Sept. 2, 2025 /PRNewswire/ -- Akeso (9926.HK) has recently announced the completion of patient enrollment in its Phase III, multicenter, randomized, controlled, registrational study evaluating ivonescimab, in combination with standard therapy, against durvalumab (PD-L1) combination the...

2025-09-02 16:00 1011
12345678 ... 1668